New Drug Approvals Archive - February 2005
Vanos (fluocinonide) Cream
Date of Approval: February 11, 2005
Treatment for: Psoriasis, Atopic Dermatitis, Dermatitis
Vanos (fluocinonide) is a corticosteroid (steroid hormone) approved to relieve the inflammation and itching caused by certain skin conditions that respond to treatment with corticosteroids in patients 12 years of age or older.
Read more: Vanos (fluocinonide) FDA Approval History
Ammonul (sodium benzoate and sodium phenylacetate) Injection
Date of Approval: February 17, 2005
Treatment for: Hyperammonemia
Ammonul (sodium benzoate and sodium phenylacetate) is indicated as an adjunctive therapy for the treatment of acute hyperammonemia and associated encephalopathy in patients with deficiencies in enzymes of the urea cycle.
Cardura XL (doxazosin mesylate)
New Formulation Approved: February 22, 2005